SharePoint
A- A A+
Home > Patients and Visitors > Find Specialist Details

​​





















image of Dr. Law Zhi Wei, David
Biodata

Dr David Law Zhiwei is a Consultant with the National Healthcare Group Eye Institute at Tan Tock Seng Hospital.

Dr Law was awarded the Singapore Armed Forces (SAF) Local Study Award (Medicine) in 1999 and completed his undergraduate studies at the Yong Loo Lin School of Medicine, National University of Singapore in 2004, where he graduated with a Bachelor of Medicine and Surgery. He was conferred the Master of Medicine (Ophthalmology) in 2016 and is a qualified Oculoplastic Surgery specialist, having completed his clinical fellowship at Bristol Eye Hospital, United Kingdom in 2018. He is a Fellow of the Academy of Medicine (Singapore) ) and a member of the Asia Pacific Society of Ophthalmic Plastic and Reconstructive Surgery (APSOPRS).

Dr Law has served in his professional capacity as a SAF Ophthalmologist, contributing to the review of ophthalmology-related medical grading and standards in the SAF. He previously held various Command level appointments in the SAF Medical Corps and Navy Medical Service, and last served as the Chief Naval Medical Officer of the Republic of Singapore Navy from 2019 - 2023, while being concurrently appointed as a Visiting Consultant in Oculoplastic Surgery at TTSH. Dr Law retired from the SAF in end-2023 after 18 years of Regular service.

Dr Law has a keen interest in orbital diseases such as Thyroid Eye Disease and IgG4-related Orbital Disease, as well as reconstruction of the eyelids following tumour excision surgery. He also has a keen interest in clinical education, quality and safety as well as operations. He is the current Quality Review Officer for the Department of Ophthalmology, TTSH.

Dr Law is also a qualified Underwater Medicine Specialist, having trained with the United States Navy in 2005. He is currently a Visiting Consultant at the Hyperbaric and Diving Medicine Centre at Singapore General Hospital, with a special interest in the management of acute ocular conditions with adjuvant hyperbaric oxygen therapy.

2024/11/14
2024/04/23
Last Updated on